This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanellakopoulou, K.
Right arrow Articles by Giamarellos-Bourboulis, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanellakopoulou, K.
Right arrow Articles by Giamarellos-Bourboulis, E. J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2009, p. 3106-3107, Vol. 53, No. 7
0066-4804/09/$08.00+0     doi:10.1128/AAC.01490-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

In Vitro Elution of Daptomycin by a Synthetic Crystallic Semihydrate Form of Calcium Sulfate, Stimulan{triangledown}

Kyriaki Kanellakopoulou,1 Periklis Panagopoulos,1 Efthymia Giannitsioti,1 Thomas Tsaganos,1 Dionyssia-Pinelopi Carrer,1 Nicolas Efstathopoulos,2 and Evangelos J. Giamarellos-Bourboulis1*

4th Department of Internal Medicine,1 2nd Department of Orthopaedics, Medical School, University of Athens, Athens, Greece2

Received 7 November 2008/ Returned for modification 28 March 2009/ Accepted 17 April 2009

A synthetic crystallic semihydrate form of calcium sulfate, Stimulan, was evaluated as a biodegradable carrier for the daily in vitro elution of daptomycin. Daptomycin and Stimulan were admixed at a ratio of 95:5. Elution lasted for 28 days. Eluted concentrations peaked on days 1 and 11, when the mean values were 1,320.1 and 949.2 µg/ml, respectively. The lowest eluted concentration was detected on day 28. These results support the application of the system described in experimental models of osteomyelitis.

* Corresponding author. Mailing address: 4th Department of Internal Medicine, ATTIKON University Hospital, 1 Rimini Str., 124 62 Athens, Greece. Phone: 30 210 58 31 994. Fax: 30 210 53 26 446. E-mail: giamarel{at}ath.forthnet.gr

{triangledown} Published ahead of print on 27 April 2009.

Antimicrobial Agents and Chemotherapy, July 2009, p. 3106-3107, Vol. 53, No. 7
0066-4804/09/$08.00+0     doi:10.1128/AAC.01490-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.





Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»